Enveda Therapeutics, Inc. announced that it has received $55 million in a round of funding on June 14, 2024. The transaction included participation from new investors, PremjiInvest, Lingotto Investment Management LLP, Microsoft Corporation, The Nature Conservancy, returning investors, Kinnevik AB, True Venture Management, LLC, FPV Ventures, LLC, Level Ventures and Jazz Venture Partners, L.P. The company has raised a total of $230 million in funding till date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.3 SEK | +2.93% | -6.69% | -15.54% |
06-14 | Enveda Therapeutics, Inc. announced that it has received $55 million in funding from a group of investors | CI |
06-05 | Kinnevik AB Approves Extra Distribution | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
445.7 USD | -0.14% | +0.93% | 3,313B | ||
91.3 SEK | +2.93% | -6.69% | 2.46B | ||
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.54% | 2.46B | |
+24.02% | 84.18B | |
+11.70% | 17.9B | |
+57.97% | 17.3B | |
+10.37% | 14.9B | |
-4.14% | 12.45B | |
+6.98% | 10.98B | |
-1.05% | 10.9B | |
+31.98% | 10.34B | |
+86.31% | 9.5B |
- Stock Market
- Equities
- KINV B Stock
- News Kinnevik AB
- Enveda Therapeutics, Inc. announced that it has received $55 million in funding from a group of investors